Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Annalisa Di Ruscio, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Annalisa Di Ruscio and Daniel Tenen.
Connection Strength

2.844
  1. DNMT1-interacting RNAs block gene-specific DNA methylation. Nature. 2013 Nov 21; 503(7476):371-6.
    View in: PubMed
    Score: 0.568
  2. Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML. Blood. 2021 Oct 14; 138(15):1331-1344.
    View in: PubMed
    Score: 0.247
  3. DNMT3B shapes the mCA landscape and regulates mCG for promoter bivalency in human embryonic stem cells. Nucleic Acids Res. 2019 08 22; 47(14):7460-7475.
    View in: PubMed
    Score: 0.213
  4. Multiple sclerosis: getting personal with induced pluripotent stem cells. Cell Death Dis. 2016 Apr 14; 7:e2185.
    View in: PubMed
    Score: 0.169
  5. The second hit of DNA methylation. Mol Cell Oncol. 2016 May; 3(3):e1093690.
    View in: PubMed
    Score: 0.164
  6. Multiple sclerosis: getting personal with induced pluripotent stem cells. Cell Death Dis. 2015 Jul 09; 6:e1806.
    View in: PubMed
    Score: 0.160
  7. Dissecting the role of aberrant DNA methylation in human leukaemia. Nat Commun. 2015 May 22; 6:7091.
    View in: PubMed
    Score: 0.159
  8. Treatment of chronic myelogenous leukemia by blocking cytokine alterations found in normal stem and progenitor cells. Cancer Cell. 2015 May 11; 27(5):671-81.
    View in: PubMed
    Score: 0.159
  9. The Runx-PU.1 pathway preserves normal and AML/ETO9a leukemic stem cells. Blood. 2014 Oct 09; 124(15):2391-9.
    View in: PubMed
    Score: 0.151
  10. Sox4 is a key oncogenic target in C/EBPa mutant acute myeloid leukemia. Cancer Cell. 2013 Nov 11; 24(5):575-88.
    View in: PubMed
    Score: 0.143
  11. In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. Blood. 2013 Feb 21; 121(8):1255-64.
    View in: PubMed
    Score: 0.134
  12. C/EBP? deregulation results in differentiation arrest in acute myeloid leukemia. J Clin Invest. 2012 Dec; 122(12):4490-504.
    View in: PubMed
    Score: 0.134
  13. Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. Blood. 2009 Dec 24; 114(27):5415-25.
    View in: PubMed
    Score: 0.107
  14. CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha. Blood. 2007 Nov 15; 110(10):3695-705.
    View in: PubMed
    Score: 0.092
  15. Core-binding factor leukemia hijacks the T-cell-prone PU.1 antisense promoter. Blood. 2021 Oct 14; 138(15):1345-1358.
    View in: PubMed
    Score: 0.062
  16. E-cadherin is regulated by GATA-2 and marks the early commitment of mouse hematopoietic progenitors to the basophil and mast cell fates. Sci Immunol. 2021 02 05; 6(56).
    View in: PubMed
    Score: 0.059
  17. Scavenging of Labile Heme by Hemopexin Is a Key Checkpoint in Cancer Growth and Metastases. Cell Rep. 2020 09 22; 32(12):108181.
    View in: PubMed
    Score: 0.057
  18. Induced pluripotent stem cells in hematology: current and future applications. Blood Cancer J. 2014 May 09; 4:e211.
    View in: PubMed
    Score: 0.037
  19. CARM1 is required for proper control of proliferation and differentiation of pulmonary epithelial cells. Development. 2010 Jul; 137(13):2147-56.
    View in: PubMed
    Score: 0.028
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.